Sy Mukherjee

Sy Mukherjee is a former health care reporter for Fortune.

Page 25 of 100

  • U.S. Health Data Trust DeficitNewsletters

    5 Health Leaders on the Trust Deficit in U.S. Medicine

    By
  • Astellas Gene Therapy DealNewsletters

    The Gene Therapy Spree Rolls on With $3 Billion Astellas Deal

    By
  • Stephen Hahn FDA Senate Panel Vote VapingHealth

    Trump’s New FDA Nominee Advances in the Senate—But Faces Tough Questions About Vaping

    By
  • Biogen Stock Alzheimer's AducanumabNewsletters

    Biogen Stock Falls After Analyst Throws Cold Water on Its Alzheimer’s Drug Bet

    By
  • Dexcom Outage DiabetesHealth

    Parents of Children With Diabetes Are Furious Following the Blackout of a Major Blood Sugar Monitoring Software

    By
  • Thanksgiving Holidays Mental HealthNewsletters

    Is Thanksgiving Good, or Bad, for Your Mental Health?

    By
  • US Life Expectancy ReportNewsletters

    American Life Expectancy Is Still Dropping. But Why?

    By
  • Novartis Amarin Cholesterol DrugsNewsletters

    Novartis’ $9.7 Billion Deal Sets off Heart Drug Wars

    By
  • Best Drugs Last 10 YearsNewsletters

    Which Medicines Have Transformed Drug Development in the Past Decade?

    By
  • Laura Esserman UCSF Salesforce BlockchainNewsletters

    Exclusive: This Doctor Wants to Use Salesforce Blockchain to Cut Cancer Drug Development Costs in Half

    By
  • Oxycontin China FlourishingNewsletters

    OxyContin’s Maker Is Still Flourishing In China

    By
  • Vertex CRISPR Sickle Cell Blood DisordersNewsletters

    A Small Study Raises Big Hopes That Gene-Editing Can Treat Blood Diseases

    By
  • CEOs on Future of Digital HealthNewsletters

    2 CEOs on the Future of Digital Health

    By
  • FORTUNE GLOBAL FORUM 2019 - Digital Health PanelConferences

    Why Virtual Brain Simulations Are the Future of Health Care

    By
  • Facebook Vaccine Misinformation StudyNewsletters

    The Source of Facebook’s Anti-Vaccine Ads

    By